Friday, November 10, 2023 through Saturday, November 11, 2023

Register Here

Payment for registration

Book your stay

Meet our keynote speakers Dr. Lydiatt and Dr. Brecht:

Dr. Bill Lydiatt is Professor of Surgery at Creighton University, Clinical Professor of Surgery UNMC, and is President-Elect of the AHNS.  He is Chair of the AJCC 9th Edition Head and Neck Staging panel and a member of the AJCC Editorial Board. He received his BS from Stanford, MD, his Otolaryngology Head and Neck Surgery Residency from University of Nebraska and his Fellowship in Head & Neck Surgical Oncology from Memorial Sloan Kettering Cancer Center, NY. Dr. Lydiatt received his EMBA from the University of Colorado. A former CMO, he has also held multiple VP positions in Medical Affairs, Surgical Services and Chair of Surgery at Nebraska Methodist Hospital.  Dr. Lydiatt has a long-standing interest in the prevention of depression in Head & Neck Cancer patients, and the use of the arts to enhance teaching and understanding of the patient experience. He has also written over 150 publications, books and book chapters in the field.

Dr. Brecht is currently the Director of Maxillofacial Prosthetics at multiple hospitals in the Northwell Health System and a Director and Adjunct Associate Clinical Professor in Postgraduate Prosthodontics at NYU College of Dentistry he also holds an appointment in the Dept of Head & Neck Surgery at MD Anderson, University of Texas. For over 25 years, Dr. Brecht was the Director of Dental Services at the Institute of Reconstructive Plastic Surgery at NYU Langone, with appointments at NYU School of Medicine in the Depts of Plastic Surgery and Otolaryngology/Head & Neck Surgery.  Brecht was also a part of teams that developed Jaw-in-a-Day (JIAD) and nasoalveolar molding (NAM). Dr. Brecht is currently President of The Maxillofacial Foundation and NextGenFace Foundation. He is a past-president of the Greater NY Academy of Prosthodontics, the American Academy of Maxillofacial Prosthetics (AAMP) and is a Fellow of the Academy of Prosthodontics and ITI (USA). He has received numerous awards, authored textbooks, lectures regularly and maintains a private practice in Manhattan.

Location

Wild Dunes Resort

Nov 10: Noon-8:30pm and Nov 11: 7:00am - 1:00pm.

5757 Palm Blvd.

Isle of Palms, SC 29451

Notes

There will be a 100% refund if registration is cancelled by 10/12/23, a 50% refund if cancelled after 10/13/23.

For any questions, please feel free to reach out to our organizers:

Overview

The incidence of head and neck cancer in the U.S. is expected to increase by 12 percent from 2020 till 2030 (CDC USCS Data). While head and neck cancer accounts for only 4 percent of all cancers in the U.S., the extensive treatment modalities, severe impact on daily living and high recurrence rate make head and neck cancer one of the most complex oncologic subspecialties to develop within the hospital (American Cancer Society).

Clinicians need up to date knowledge of care management for patients with head and neck cancer. We educate on updates in surgical advances, chemotherapy and immunotherapy developments, clinical trials, radiation therapy, and technology evolution for reconstruction. In addition to covering clinical advancements, we educate on the multidisciplinary team vital to treating head and neck cancer patients. The responsibilities of surgeons, radiation oncologists, medical oncologists, pathologists, social workers, nurse navigators, speech and language pathologists and maxillofacial prosthodontics will be covered at length with panels teaching how to create highly effective and collaborative multidisciplinary teams.

Agenda

DAY 1: Friday, November 10

11:30am - Lunch with the Experts

12:25pm – Opening remarks: Terry Day, MD

12:30pm Innovations in the Treatment of Head & Neck in Cutaneous Cancer- Brian Gross, MD, FACS, CPE & Kimberly Aderhold, DO

12:50pm Ameloblastoma and Odontogenic Keratocyst - Brad Neville, DDS

1:10pm Strategy, Development, and Delivery of Head and Neck Radiotherapy Services via a Community-Based Network - Andrew Kennedy, MD

1:30pm Sentinel Node Biopsy in Management of Melanoma - Eric Lentsch, MD

2:00pm Keynote Speaker: Maxillary Reconstruction: Prosthodontic Perspectives - Lawrence Brecht, DDS

2:45pm Maxillofacial Case Review - Betsy Davis, DDS

3:00pm Break

3:20pm Oral Cavity Panel - Controversies in Oral Cancer Management

  • Moderator: David Neskey, MD, MSCR, FACS
  • Panel Participants: Azeem Kaka, MD, Lawrence Brecht, DDS, William Lydiatt, MD, Hannah Cornett, MS, CCC-SLP, BCS-S, Steven Hong, MD

3:40pm Advancements in Virtual Surgical Planning - Jim Bekeny, MD

4:00pm Local & Regional Flap Head & Neck Reconstruction - Peter Horwich, MD, FRCSC

4:20pm Advances in Free Flap Reconstruction of the Head & Neck - Azeem Kaka, MD

6:30pm - 8:30pm Welcome Reception

DAY 2: Saturday, November 11

7:30am Breakfast with the Experts

8:30am Approaches to Parotid Neoplasms - Serat K. Poonia, MD

8:50am Radiofrequency Ablation vs. Thyroidectomy for Thyroid Nodules - Joshua Hornig, MD, FRCSC

9:10am Technological Advances in Parathyroid Surgery - Sham Tantry, MD

9:30am Paragangliomas in the Head & Neck - Ken Byrd, MD

10:00am Keynote Speakers: Rumsfeld, Risk and Rembrandt: Exploring the Many Facets of Medical Decision Making - William Lydiatt, MD

10:45am Break with Refreshments

11:15am Extracapsular Extension of Cervical Lymph Nodes: Now & Then - Jeffrey Houlton, MD

11:35am Evaluating Candidacy for Primary or Secondary Tracheoesophageal Puncture (TEP) for Communication in the Total Laryngectomy Patient - Hannah Cornett, MS, CCC-SLP, BCS-S

11:55am Indications for Nasal & Orbital Prosthetics in Head & Neck Defects - Betsy Davis, DDS, Michelle Ruse, DDS

12:15pm Prevention & Management of Depression in Head & Neck Cancer Patients - William Lydiatt, MD

12:30pm Evolutions in Management of Oropharyngeal Cancer

  • Moderator: Terry Day, MD
  • Panel Participants: Paul Lawson Davis III, MD, FACS, Jordan Rawl, MD, Andrew Kennedy, MD, Andrew Nemechek, MD, MS, FACS, Kimberly Aderhold, DO

1:00pm Closing Remarks, CME Certificates

Target audience

Clinicians caring for head and neck cancer patients, including but not limited to: ENT, oral and maxillofacial surgeons, endocrinologists, speech-language pathologists, nurse navigators, radiation oncologists, medical oncologists, pathologists, head and neck surgeons, dentists, medical residents, social workers, fellows in oncologic specialties.

Learning objectives

Upon conclusion of this symposium, learners should be able to:

  1. Diagnose, manage and treat salivary and neoplasms cancers (head and neck cancer) with the multidisciplinary care team to improve patient experience and outcomes.
  2. Apply new advancements in the care management of oral and oropharyngeal cancers, including multidisciplinary treatment and collaboration.
  3. Integrate survivorship into the post-treatment algorithm to ensure psychosocial and quality-of-life endpoints are incorporated into the patient's care.

Course director(s)

  • Jeffrey Houlton, MD

Speaker(s)


Peter Horwich, MD, FRCSC


Jeffrey Houlton, MD


Betsy K. Davis, DMD, MS


Hannah Cornett, MS, CCC-SLP, BCS-S


Lawrence Brecht, DDS


Bill Lydiatt, MD, EMBA

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare South Atlantic Division. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians

Credit designation

The HCA Healthcare Continental Division designates this live activity for a maximum of 8.0 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial support 

This activity was developed without support from any ineligible company .*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients as commercial interests – unless the provider of clinical services is owned, controlled by, and ACCME defined as an ineligible company.

Disclosure

The HCA Healthcare Continental Division is committed to providing balanced, objective, and evidence-based CME. Per the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence, all parties involved in content development must disclose all conflicts of interest with ACCME-defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose before delivering any educational activity. The CME planning committee, which is in a position to control the content of this CME Activity, has no relevant financial relationships with ineligible companies to disclose.

Available credit

8.00 AMA PRA Category 1 Credit™

HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HCA Healthcare Continental Division designates this for a maximum of 8.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

8.00 Attendance